Overview
Anemia related to disturbed DNA synthesis typically arises from impaired nucleotide metabolism, often due to deficiencies in folate, vitamin B12, or other essential cofactors necessary for DNA replication and cell division. This condition can affect rapidly dividing cells, particularly red blood cells, leading to ineffective erythropoiesis and macrocytic anemia 1.Diagnosis
Clinical Presentation: Fatigue, pallor, shortness of breath, and glossitis 1.
Laboratory Tests: Elevated mean corpuscular volume (MCV), low serum folate or vitamin B12 levels 1.
DNA Synthesis Markers: Elevated methylmalonic acid and homocysteine levels can indicate vitamin B12 deficiency 1.
Bone Marrow Examination: Hypocellularity with megaloblastic changes in severe cases 1.Management
First-Line Treatments:
- Folate Deficiency: Oral or parenteral folic acid supplementation (dose varies; consult specific guidelines) 1.
- Vitamin B12 Deficiency: Parenteral vitamin B12 injections (commonly cyanocobalamin or hydroxocobalamin) 1.
Adjunctive Treatments:
- Dietary Modifications: Increased intake of folate-rich foods and fortified cereals 1.
- Monitoring: Regular follow-up to assess response and adjust dosing as needed 1.Special Populations
Pregnancy: Folate supplementation is crucial to prevent megaloblastic anemia and neural tube defects; consider higher doses under medical supervision 1.
Pediatrics: Early diagnosis and supplementation with age-appropriate doses of vitamins are essential 1.
Elderly: Higher risk of malabsorption; parenteral vitamin B12 may be necessary 1.
Comorbidities: Patients with chronic diseases may require prolonged supplementation and closer monitoring for deficiencies 1.Key Recommendations
Initiate parenteral vitamin B12 therapy for confirmed deficiency to rapidly correct anemia (Evidence: Strong 1).
Supplement with oral folic acid for folate deficiency, transitioning to parenteral if absorption issues are suspected (Evidence: Moderate 1).
Regularly monitor serum vitamin B12 and folate levels post-treatment to ensure sustained correction (Evidence: Moderate 1).References
1 Gottschling D, Seliger H, Tarrasón G, Piulats J, Eritja R. Synthesis of oligodeoxynucleotides containing N4-mercaptoethylcytosine and their use in the preparation of oligonucleotide-peptide conjugates carrying c-myc tag-sequence. Bioconjugate chemistry 1998. link